InicioSOLACI-SOCIME 2025 - Presentaciones seleccionadas

SOLACI-SOCIME 2025 - Presentaciones seleccionadas

Presentaciones seleccionadas Congreso SOLACI-SOCIME 2025

Encuentre a continuación algunas presentaciones seleccionadas por el consejo editorial de la web de SOLACI.

Día 1

Dr. Agustín Chozas (AR)

Multiple, apical and complex VSDs: the art of closing what seems impossible

Dr. Alejandro Ricalde Alcocer (MX)

Stent thrombosis and restenosis in diabetes mellitus patients.

Dr. Anibal Damonte (AR)

How to avoid the mismatch

Dra. Carla Agatiello (AR)

Aortic stenosis in women: a different disease

Dr. Carlos Guerrero (CHL)

To close or not to close: tough decisions in adult ASD with borderline physiology

Dra. Claudia González Zúñiga (MX)

PCI in stable heart disease and diabetes mellitus

Dr. Emanuele Barbato (IT)

Coronary protection techniques in high-risk patients

Dr. Flavio Ribichini (IT)

My best strategy in TAVI with coronary artery disease. When to treat?

Dr. Guering Eid-Lidt (MX)

Advances in Mitral Valve-in-Valve

Dr. Jesús Damsky Barbosa (AR)

From the registry to the cath lab: strategy and execution in SVS ASD closure

Dr. Juan Granada (US)

Mitral valve replacement: Where are we going?

Dr. Juan Granada (US)

The future of transcatheter intervention of chronic heart failure

Dra. Liliana Ferrín (AR)

When to close? The ideal timing in patients with VSD and signs of overload

Dra. Mayra Guerrero (US)

Keynote Lecture. Treatment of LVOT Obstruction

Dr. Said Vega (MX)

Seeing the Unseen: OCT in Calcium Detection and Treatment Planning

Dr. Srihari Naidu (USA)

Keynote Lecture. Alcohol Septal Ablation Versus Surgical Treatment in MCH

Día 2

Dr. Mauro echavarria pinto (MEX)

The role of image in defining the mechanism of late stent failure

Dr. Flavio Ribichini (IT)

Cerebrovascular events in transfemoral TAVI

Dr. Hayder Hashim (USA)

Invasive vs conservative management in SCAD

Dra. Clarissa Dall (BRA)

Culprit or complete revascularization in AMI cardiogenic shock

Dr. Mayra Guerrero (USA)

MTVR (Mitral Trials) what have we learned?

Dr. Mauro Echavarria Pinto (MEX)

Long term follow up of PCI guided by FFR

Dra. Carla Agatiello (ARG)

Impact of small valve size after TAVI in women. WIN TAVI registry

Dr. Ajay. J Kirtane (USA)

Crossing strategy selection

Dr. Matthew Price (USA)

One device many anatomies: The versatility of WATCHMAN FLX in LAAC

Dr. Mayra Guerrero (USA)

EARLY TAVR TRiaL: Confirmed data and data to be reviewed

Dr. Pedro Villablanca (USA)

Which asymptomatic patients with severe aortic valve stenosis should follow the route of early TAVR?

Día 3

Dr. Mario Araya (CL)

DEB in small vessels

Dr. Matthew Price (US)

Keynote lecture. Latest in tricuspid transcatheter interventio

Dra. Andrea Robaina (VE)

Review of the state of the art of the literature on FFR

Dr. Santiago García (US)

Aortic Regurgitation: The Need for and Status of Dedicated TAVR Devices

Dr. Camilo Gomez (USA)

Bicuspid valve update

Dr. Jesus diaz Marin (MXN)

Lithotripsy in severe calcification of femoral artery

Dr. Jose Luis Leiva Pons (MXN)

Advances in thromboaspiration devices Primary pCI

SOLACI-SOCIME 2025 - Presentaciones seleccionadas

Presentaciones seleccionadas Congreso SOLACI-SOCIME 2025

Día 1

Día 2

Día 3

Últimas Noticias

Perforaciones coronarias y el uso de stents recubiertos: ¿una estrategia segura y eficaz a largo plazo?

¿Un nuevo paradigma en la estenosis carotídea asintomática? Resultados unificados del ensayo CREST-2

Remodelado cardíaco luego del cierre percutáneo de la CIA: ¿inmediato o progresivo?

Noticias Institucionales

Vuelva a ver Embolia pulmonar en 2025: estratificación de riesgo y nuevas aproximaciones terapéuticas

Vuelva a ver SELUTION: Balón liberador de sirolimus para lesiones coronarias de novo – Nueva evidencia y perspectivas clínicas

25/11 – Webinar SOLACI: Embolia Pulmonar en 2025 – Estratificación de riesgo y nuevas aproximaciones terapéuticas

Accesos